Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Mirvetuximab Soravtansine: First Approval

PaperCitations, authors & open-access status

Mirvetuximab Soravtansine: First Approval is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 110 citations, 2023 year and green oa status.

110
Citations
2023
Year
green
OA Status

Related on ScholarIQ

Young‐A Heo
Author
Drugs
Journal
Ovarian cancer diagnosis and treatment
Topic
Ovarian cancer diagnosis and treatment
Topic
PARP inhibition in cancer therapy
Topic
Advanced Breast Cancer Therapies
Topic
470M+ articles · free account